Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates

Walters, JN; Schouest, B; Patel, A; Reuschel, EL; Schultheis, K; Parzych, E; Maricic, I; Gary, EN; Purwar, M; Andrade, VM; Doan, A; Elwood, D; Eblimit, Z; Nguyen, B; Frase, D; Zaidi, FI; Kulkarni, A; Generotti, A; Kim, JJ; Humeau, LM; Ramos, SJ; Smith, TRF; Weiner, DB; Broderick, KE

Broderick, KE (通讯作者)，Inovio Pharmaceut, Plymouth Meeting, PA 19462 USA.;Weiner, DB (通讯作者)，Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, Philadelphia, PA 19104 USA.

VACCINE, 2022; 40 (21): 2960

Abstract

The enhanced transmissibility and immune evasion associated with emerging SARS-CoV-2 variants demands the development of next-generation vaccines capa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索